UNITY Biotechnology, Inc. reported financial results for the fourth quarter and full year ended December 31, 2023. “On the heels of positive BEHOLD data, our team...
Adherium Limited announced that its innovative Hailie® Smartinhaler® has received clearance from the U.S. Food and Drug Administration (FDA) for use with AstraZeneca’s Airsupra® and Breztri®...
Beckman Coulter Diagnostics announced ahead of the congress of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID Global), that it has extended the menu...
When developing new drugs, nutritional products, or pesticides, it’s critical that unknown molecules are identified correctly. But accurate identification is a lengthy process and all too...
The FDA has identified this as a Class I recall, the most serious type of recall. Use of these devices may cause serious injuries or death....
Smiths Medical’s recall of more than 2,900 emergency ventilators has reverberated throughout the transport ventilator market. Concerns regarding device reliability and safety have prompted healthcare providers...
On March 15, 2024, Genmab announced the initiation of a share buy-back program to repurchase up to DKK 3.5 billion worth of shares. The share buy-back...
Mobile-health Network Solutions announced the closing of its previously announced initial public offering of an aggregate 2,250,000 Class A Ordinary Shares (“the Offering”) at a price...
Notable Labs, Ltd. reported financial results for the year ended December 31, 2023 and provided a business update. “The last year has been a time of...
Simpson Interventions, Inc. announced that its groundbreaking Acolyte Image Guided Crossing and Re-Entry Catheter System has been granted Breakthrough Device Designation by the U.S. Food and...
Oncocyte Corporation reported financial results for the year ended December 31, 2023. “In 2023, we made significant progress on cost controls and in the development of...
DeepCure announced the closing of a $24.6 million Series A-1 financing led by IAG Capital Partners (IAG) with participation from the company’s current investors. DeepCure has...
Illumina, Inc. announced it has received approval of its divestment plan for GRAIL from the European Commission (EC). While this does not mean the method of...
Magnetic Insight has announced the appointment of Chris A. Raanes as the company’s new CEO effective February 21st, a joint grant with The University of California...
Biomerica, Inc. reported financial results for the third quarter of fiscal 2024 ended February 29, 2024. “We are excited about the sales growth of our inFoods...
Copyright © 2024 Medical Buyer